MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD – Get Free Report) shares traded down 1% during trading on Monday . The stock traded as low as $0.88 and last traded at $0.88. 183,880 shares were traded during trading, an increase of 37% from the average session volume of 134,123 shares. The stock had previously closed at $0.89.
MyMD Pharmaceuticals Stock Performance
The company has a 50 day simple moving average of $1.23 and a 200 day simple moving average of $1.48.
About MyMD Pharmaceuticals
MyMD Pharmaceuticals, Inc, a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system and its pro-inflammatory cytokines to prevent and treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for sarcopenia, multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis; inflammation related depression and anxiety; and COVID-19-associated depression.
Featured Articles
- Five stocks we like better than MyMD Pharmaceuticals
- What Do S&P 500 Stocks Tell Investors About the Market?
- How to Invest in Small Cap Stocks
- How to Capture the Benefits of Dividend Increases
- These Are the Dividend Stocks Insiders Bought in January
- EV Stocks and How to Profit from Them
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for MyMD Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MyMD Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
